CHRONIC KIDNEY DISEASE (CKD)/END STAGE KIDNEY DISEASE (ESKD) Flashcards
GFR (kidney function) is used to stage
chronic kidney disease
eGFR considers creatinine levels, gender, race, and body size but it only used for screening & antibiotic/med dosing.
True or False
True
GFR > 90mL/min
At risk, normal kidney function but urine findings, structural abnormalities, or genetic trait points to kidney disease
Stage 1
GFR 60-89mL/min
Mild CKD; reduced kidney function; lab values and other findings point to kidney disease
Focus on reduction of risk factors
Stage 2
GFR 30-59mL/min
Moderate CKD
Implement strategies to slow disease progression
Stage 3
GFR 15-29mL/min
Severe CKD
Manage complications; Education on renal replacement therapy
Stage 4
GFR < 15mL/min
End stage kidney disease (ESKD)
Implement renal replacement therapy or kidney transplant
Stage 5
What is the leading cause of death in patients with ESKD?
CVD
Is CKD/ESKD reversible?
No. It is progressive, irreversible, w/no recovery.
S/Sx
- Uremia
- Azotemia
- Anuria
- Uremic fetor
- Stomatitis
- Halitosis
- Metallic taste in mouth/anorexia/nausea
- Polyuria
- Pruritis
- HTN
- Hyperlipidemia
- Anemia
- Increased risk of infection
Erythropoietin injections for
anemia
Manifestations of ESKD
Neuro: HA, weakness & fatigue, sleep disturbances
Cardio: ^BP, Pitting edema, HF, PAD
Pulm: pulmonary edema, pneumonia
GI: ammonia odor breath, metallic taste, anorexia, NV, GI bleeding
Psych: withdrawn, depressed, behavioral changes
Hematologic: anemia, infection, bleeding tendencies
Fluid and electrolytes: ^Pot, metabolic acidosis
Skin: dry & flaky, pruritis, ecchymosis, yellow-grey color
Musculoskeletal: cramps, bone pain, renal osteodystrophy
- Decrease calcium (Trousseau’s Sign, Chvostek’s Sign, Fractures)
- Increased clotting time
- Anxiety and irritability
- Heart arrhythmias
- Increased serum calcium and serum phosphorus
- Vascular and soft tissue calcifications - > calcium is deposited in atherosclerotic plaques in the lining of blood vessels - > increased CVD
CKD-MBD (Mineral and Bone Disorder)/Renal Osteodystrophy
Risk factors for CKD
diabetes, hypertension, age>60, cardiovascular disease, family hx of CKD, exposure to nephrotoxic drugs, ethnic minority (African American, Native American)
Nephrotoxic drugs
antibiotics/antimicrobials, aminoglycoside antibiotics, chemotherapy agents, NSAIDs
Others- acetaminophen, metformin, pesticides, radiographic contrast medium, fungicides, arsenic, lead, copper sulfate, bismuth